May 9, 2017 / 8:29 PM / 3 months ago

BRIEF-Foamix Pharmaceuticals reports Q1 2017 financial results

May 9 (Reuters) - Foamix Pharmaceuticals Ltd:

* Foamix reports first quarter 2017 financial results and provides business update

* Q1 loss per share $0.39

* Q1 revenue $927,000 versus $745,000

* Says as of march 31, 2017, we had cash and investments of $118.7 million, compared with $131.0 million as of december 31, 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below